Glutathione S-transferase and glutathione peroxidase are essential in the early stage of Adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells

被引:24
作者
Lee, WP [1 ]
Lee, CL [1 ]
Lin, HC [1 ]
机构
[1] NATL DEF MED CTR,DEPT PHARMACOL,TAIPEI 10764,TAIWAN
关键词
MDR; P-glycoprotein; GSH; GST; GPX;
D O I
10.1007/s002800050446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have previously established Adriamycin-resistant HOB1 cell lines showing the multidrug resistance (MDR) phenotype. For further study, we analyzed the free-radical scavengers glutathione S-transferase (GST) and glutathione peroxidase (GPX) by enzyme assays and Northern blots. Three cell lines, HOB1/ADR0.1, HOB1/ADR1.0, and HOB1/ADR5.0, represented HOB1 cells resistant to 0.1, 1.0, and 5.0 mu M Adriamycin, respectively. The mdr1 transcript was overexpressed in HOB1/ADR0.1 cells, and the amount of its expression reached a maximum between HOB1/ADR1.0 and HOB1/ADR5.0 cell lines. The increases in GST activity and GST-pi expression were observed only in high-level-resistant cell lines (HOB1/ADR1.0 and HOB1/ADR5.0), which also showed increased GPX activity and expression. For investigation of the cytotoxic effect of Adriamycin on HOB1 cells prior to the mdr1 overexpression, an appropriate number of parental HOB1 cells were treated with 0.1 mu M Adriamycin for 7 days, and the viable cells (HOB1/ADR) were isolated and subjected to analyses for mdr1, GST-pi, and GPX expression and for GST and GPX activity. In comparison with HOB1/ADR0.1 cells, HOB1/ADR cells did not show mdr1 overexpression but had significant increases in the activity and expression of GST and GPX. The current study suggests that in the early phase of Adriamycin treatment, GST and GPX are more important than P-glycoprotein for the development in HOB1 cells of resistance against Adriamycin.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 57 条
[41]   HYDROXYL RADICAL PRODUCTION AND DNA DAMAGE INDUCED BY ANTHRACYCLINE-IRON COMPLEX [J].
MUINDI, JRF ;
SINHA, BK ;
GIANNI, L ;
MYERS, CE .
FEBS LETTERS, 1984, 172 (02) :226-230
[42]  
NAKAGAWA K, 1990, J BIOL CHEM, V265, P4296
[43]  
PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
[44]  
PEPER RJ, 1968, J LAB CLIN MED, V72, P842
[45]   COMPARATIVE UPTAKE, RETENTION AND ACTION OF VINCRISTINE, VINBLASTINE AND VINDESINE ON MURINE LEUKEMIC LYMPHOBLASTS SENSITIVE AND RESISTANT TO VINCRISTINE [J].
RIVERAFILLAT, MP ;
PALLARESTRUJILLO, J ;
DOMENECH, C ;
GRAUOLIETE, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :902-908
[46]  
RUSSO A, 1985, CANCER TREAT REP, V69, P1293
[47]  
SAMUELS BL, 1991, CANCER RES, V51, P521
[48]  
SCHNEIDER E, 1994, CANCER RES, V54, P152
[49]   ESTIMATION OF TOTAL PROTEIN-BOUND AND NONPROTEIN SULFHYDRYL GROUPS IN TISSUE WITH ELLMANS REAGENT [J].
SEDLAK, J ;
LINDSAY, RH .
ANALYTICAL BIOCHEMISTRY, 1968, 25 (1-3) :192-&
[50]   FREE-RADICALS AND ANTICANCER DRUG-RESISTANCE - OXYGEN FREE-RADICALS IN THE MECHANISMS OF DRUG CYTOTOXICITY AND RESISTANCE BY CERTAIN TUMORS [J].
SINHA, BK ;
MIMNAUGH, EG .
FREE RADICAL BIOLOGY AND MEDICINE, 1990, 8 (06) :567-581